Literature DB >> 19731390

Fetal alcohol spectrum disorders: when science, medicine, public policy, and laws collide.

Kenneth R Warren1, Brenda G Hewitt.   

Abstract

Historically, alcohol has been used for different purposes including as a part of religious observances, as a food, at times as a medicine and its well-known use as a beverage. Until relatively recently these purposes have not changed and have at times been at odds with one another, resulting in collisions among policies and practices in science, medicine, public policy and the law. One area in which this has been particularly true is that of fetal alcohol spectrum disorders (FASD) where the adverse consequences of consumed alcohol on children in the womb and after birth may have been observed since antiquity, but the actions taken based on such observations have been influenced as much by the socio/cultural/political context of the times in which they were made as by evidence of harm. This article provides an overview of the inherent confusion when new scientific findings confront prevailing medical practice, the history involved in this confusion with respect to FASD, including public policy and legal issues that have arisen around alcohol and pregnancy, and the research and clinical challenges still being faced. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19731390     DOI: 10.1002/ddrr.71

Source DB:  PubMed          Journal:  Dev Disabil Res Rev        ISSN: 1940-5529


  9 in total

1.  Detection of alcohol use in the second trimester among low-income pregnant women in the prenatal care settings in Jefferson County, Alabama.

Authors:  Qing Li; Janet Hankin; Sharon C Wilsnack; Ernest L Abel; Russell S Kirby; Louis G Keith; Sarah G Obican
Journal:  Alcohol Clin Exp Res       Date:  2012-02-29       Impact factor: 3.455

2.  The safe passage study: design, methods, recruitment, and follow-up approach.

Authors:  Kimberly A Dukes; Larry Burd; Amy J Elliott; William P Fifer; Rebecca D Folkerth; Gary D V Hankins; Dale Hereld; Howard J Hoffman; Michael M Myers; Hein J Odendaal; Caroline Signore; Lisa M Sullivan; Marian Willinger; Colleen Wright; Hannah C Kinney
Journal:  Paediatr Perinat Epidemiol       Date:  2014-08-05       Impact factor: 3.980

3.  Predictors of alcohol use prior to pregnancy recognition among township women in Cape Town, South Africa.

Authors:  Mary J O'Connor; Mark Tomlinson; Ingrid M Leroux; Jacqueline Stewart; Erin Greco; Mary Jane Rotheram-Borus
Journal:  Soc Sci Med       Date:  2010-10-23       Impact factor: 4.634

Review 4.  Perinatal exposure to alcohol: implications for lung development and disease.

Authors:  Danielle Giliberti; Sowmya S Mohan; Lou Ann S Brown; Theresa W Gauthier
Journal:  Paediatr Respir Rev       Date:  2012-06-29       Impact factor: 2.726

5.  Drinking During Pregnancy and the Developing Brain: Is Any Amount Safe?

Authors:  Michael E Charness; Edward P Riley; Elizabeth R Sowell
Journal:  Trends Cogn Sci       Date:  2016-02       Impact factor: 20.229

6.  State Responses to Alcohol Use and Pregnancy: Findings From the Alcohol Policy Information System (APIS).

Authors:  Laurie Drabble; Sue Thomas; Lisa O'Connor; Sarah Cm Roberts
Journal:  J Soc Work Pract Addict       Date:  2014-01-01

7.  Messages that increase women's intentions to abstain from alcohol during pregnancy: results from quantitative testing of advertising concepts.

Authors:  Kathryn E France; Robert J Donovan; Carol Bower; Elizabeth J Elliott; Janet M Payne; Heather D'Antoine; Anne E Bartu
Journal:  BMC Public Health       Date:  2014-01-13       Impact factor: 3.295

8.  The Presence and Consequences of Abortion Aversion in Scientific Research Related to Alcohol Use during Pregnancy.

Authors:  Sarah C M Roberts
Journal:  Int J Environ Res Public Health       Date:  2019-08-13       Impact factor: 3.390

9.  Fetal alcohol spectrum disorders from childhood to adulthood: a Swedish population-based naturalistic cohort study of adoptees from Eastern Europe.

Authors:  Valdemar Landgren; Leif Svensson; Emelie Gyllencreutz; Eva Aring; Marita Andersson Grönlund; Magnus Landgren
Journal:  BMJ Open       Date:  2019-10-30       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.